BioNTech SE (BNTX) scores 35 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $22.62, representing a 74% premium to fair value. Quantitative score: 50/100. Qualitative score: 30/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.